Literature DB >> 11359908

Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci.

L J Huber1, T W Yang, C J Sarkisian, S R Master, C X Deng, L A Chodosh.   

Abstract

Both human and mouse cells express an alternatively spliced variant of BRCA1, BRCA1-Delta11, which lacks exon 11 in its entirety, including putative nuclear localization signals. Consistent with this, BRCA1-Delta11 has been reported to reside in the cytoplasm, a localization that would ostensibly preclude it from playing a role in the nuclear processes in which its full-length counterpart has been implicated. Nevertheless, the finding that murine embryos bearing homozygous deletions of exon 11 survive longer than embryos that are homozygous for Brca1 null alleles suggests that exon 11-deleted isoforms may perform at least some of the functions of Brca1. We have analyzed both the full-length and the exon 11-deleted isoforms of the murine Brca1 protein. Our results demonstrate that full-length murine Brca1 is identical to human BRCA1 with respect to its cell cycle regulation, DNA damage-induced phosphorylation, nuclear localization, and association with Rad51. Surprisingly, we show that endogenous Brca1-Delta11 localizes to discrete nuclear foci indistinguishable from those found in wild-type cells, despite the fact that Brca1-Delta11 lacks previously defined nuclear localization signals. However, we further show that DNA damage-induced phosphorylation of Brca1-Delta11 is significantly reduced compared to full-length Brca1, and that gamma irradiation-induced Rad51 focus formation is impaired in cells in which only Brca1-Delta11 is expressed. Our results suggest that the increased viability of embryos bearing homozygous deletions of exon 11 may be due to expression of Brca1-Delta11 and suggest an explanation for the genomic instability that accompanies the loss of full-length Brca1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359908      PMCID: PMC87063          DOI: 10.1128/MCB.21.12.4005-4015.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

Review 1.  Nuclear targeting of proteins: how many different signals?

Authors:  D Christophe; C Christophe-Hobertus; B Pichon
Journal:  Cell Signal       Date:  2000-05       Impact factor: 4.315

2.  Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1.

Authors:  L Zheng; H Pan; S Li; A Flesken-Nikitin; P L Chen; T G Boyer; W H Lee
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

3.  BRCA1 physically and functionally interacts with ATF1.

Authors:  Y Houvras; M Benezra; H Zhang; J J Manfredi; B L Weber; J D Licht
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

4.  Differential expression and subcellular localization of murine BRCA1 and BRCA1-delta 11 isoforms in murine and human cell lines.

Authors:  R Bachelier; N Dalla Venezia; S Mazoyer; L Frappart; G M Lenoir; A Vincent
Journal:  Int J Cancer       Date:  2000-11-15       Impact factor: 7.396

5.  A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.

Authors:  T T Paull; E P Rogakou; V Yamazaki; C U Kirchgessner; M Gellert; W M Bonner
Journal:  Curr Biol       Date:  2000 Jul 27-Aug 10       Impact factor: 10.834

6.  Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.

Authors:  R S Tibbetts; D Cortez; K M Brumbaugh; R Scully; D Livingston; S J Elledge; R T Abraham
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

7.  Ataxia telangiectasia-related protein is involved in the phosphorylation of BRCA1 following deoxyribonucleic acid damage.

Authors:  J Chen
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

8.  BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer.

Authors:  D A Bochar; L Wang; H Beniya; A Kinev; Y Xue; W S Lane; W Wang; F Kashanchi; R Shiekhattar
Journal:  Cell       Date:  2000-07-21       Impact factor: 41.582

9.  An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

Authors:  S A Narod; D Ford; P Devilee; R B Barkardottir; H T Lynch; S A Smith; B A Ponder; B L Weber; J E Garber; J M Birch
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  BRCA1-associated growth arrest is RB-dependent.

Authors:  O N Aprelikova; B S Fang; E G Meissner; S Cotter; M Campbell; A Kuthiala; M Bessho; R A Jensen; E T Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

View more
  41 in total

Review 1.  Emerging roles of BRCA1 alternative splicing.

Authors:  T I Orban; E Olah
Journal:  Mol Pathol       Date:  2003-08

2.  Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform.

Authors:  Sang Soo Kim; Liu Cao; Sung-Chul Lim; Cuiling Li; Rui-Hong Wang; Xiaoling Xu; Richard Bachelier; Chu-Xia Deng
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

3.  BRCA1 and BRCA2 in breast cancer predisposition and recombination control.

Authors:  Ralph Scully; Anyong Xie
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

Review 4.  BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability.

Authors:  Amal Aly; Shridar Ganesan
Journal:  J Mol Cell Biol       Date:  2011-02       Impact factor: 6.216

5.  Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1.

Authors:  Sang Soo Kim; Liu Cao; Cuiling Li; Xiaoling Xu; L Julie Huber; Lewis A Chodosh; Chu-Xia Deng
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 6.  53BP1: pro choice in DNA repair.

Authors:  Michal Zimmermann; Titia de Lange
Journal:  Trends Cell Biol       Date:  2013-10-04       Impact factor: 20.808

7.  Understanding missense mutations in the BRCA1 gene: an evolutionary approach.

Authors:  Melissa A Fleming; John D Potter; Christina J Ramirez; Gary K Ostrander; Elaine A Ostrander
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-16       Impact factor: 11.205

8.  BRCA1 pathway function in basal-like breast cancer cells.

Authors:  Sarah J Hill; Allison P Clark; Daniel P Silver; David M Livingston
Journal:  Mol Cell Biol       Date:  2014-08-04       Impact factor: 4.272

9.  BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks.

Authors:  Ulrica K Westermark; Marsha Reyngold; Adam B Olshen; Richard Baer; Maria Jasin; Mary Ellen Moynahan
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 10.  Preclinical mouse models for BRCA1-associated breast cancer.

Authors:  R M Drost; J Jonkers
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.